-
Open PhD position: Autonomous Bioactivity Searching Subject area: Drug Discovery, Laboratory Automation, Machine Learning Overview: This 42-month funded PhD studentship will contribute to cutting
-
This PhD project aims to advance Safe and Sustainable by Design (SSbD) pharmaceutical manufacturing by integrating cutting-edge methodologies, including computer-assisted retrosynthesis, end-to-end
-
Drug-resistant fungal infections—caused by species like Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus—pose a growing threat in healthcare, with mortality rates exceeding 50% in
-
, coronaviruses, influenza, pneumonia, RSV) as well as pollution, tobacco, pollen, weather, drugs, foods and stinging insects. The long-term plan for the Driver Programme is to extend the data science capabilities
-
The project aims to develop a publicly accessible in silico database that identifies and catalogues bacterial genes capable of altering the effectiveness of chemotherapy drugs in colorectal cancer
-
work together with the PhD candidate. Applicants are encouraged to familiarize themselves with our existing publications . In this work, there is also an expectation to be innovation-oriented, to help us
-
Supervisors: Prof. Reinhard Maurer, Prof. Scott Habershon In drug discovery, millions of molecules need to be screened for their viability as drug candidate, including their synthetic viability
-
Do you want to design and construct synthetic life-like cells? A major goal of synthetic biology is to create life-like artificial cells from non-living components, i.e. the bottom-up approach